Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials
暂无分享,去创建一个
Yun-Tao Zhao | Mulei Chen | Cui-Lian Weng | Xingchang Yang | Kui-bao Li | Xiangmin Lin | Y. Ge | Wen-shu Zhao | Jin Chen | Lin Zhang | Jun-Xiang Yin
[1] G. Paolisso,et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. , 2009, Journal of the American College of Cardiology.
[2] P. Raskin,et al. Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2008, Anesthesiology.
[3] R. Arora,et al. Glucose-insulin-potassium therapy in patients with STEMI. , 2008, JAMA.
[4] R. Kloner,et al. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection. , 2008, Circulation.
[5] L. Opie. Metabolic Management of Acute Myocardial Infarction Comes to the Fore and Extends Beyond Control of Hyperglycemia , 2008, Circulation.
[6] P. Raskin,et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. , 2008, Circulation.
[7] H. Krumholz,et al. Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk , 2008, Circulation.
[8] S. Yusuf,et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. , 2007, JAMA.
[9] J. Ottervanger,et al. One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II. , 2007, International journal of cardiology.
[10] P. Armstrong,et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. , 2006, European heart journal.
[11] J. Ottervanger,et al. Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II. , 2006, Journal of the American College of Cardiology.
[12] M. Mclean,et al. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. , 2006, Diabetes care.
[13] J. Marinković,et al. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. , 2005, The American journal of cardiology.
[14] J Herlitz,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.
[15] L. Opie,et al. A challenge to the metabolic approach to myocardial ischaemia. , 2005, European heart journal.
[16] J. Ottervanger,et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. , 2005, Journal of the American College of Cardiology.
[17] M. Halkos,et al. Postconditioning A new link in nature’s armor against myocardial ischemia–reperfusion injury , 2005, Basic Research in Cardiology.
[18] A. Ceriello. Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. , 2005, European heart journal.
[19] Jun Zhu,et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.
[20] S. Nekolla,et al. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. , 2004, American heart journal.
[21] Michael F. Wilson,et al. Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment–Elevation Myocardial Infarction , 2004, Circulation.
[22] M. Galiñanes,et al. Role of clinical pathologies in myocardial injury following ischaemia and reperfusion. , 2004, Cardiovascular research.
[23] K. Kawecka-Jaszcz,et al. Low-Dose Glucose-Insulin-Potassium Is Ineffective in Acute Myocardial Infarction: Results of a Randomized Multicenter Pol-GIK Trial , 1999, Cardiovascular Drugs and Therapy.
[24] Felix Zijlstra,et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. , 2003, Journal of the American College of Cardiology.
[25] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[26] D. Yellon,et al. Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling , 2001, Circulation research.
[27] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[28] M. Egger,et al. The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.
[29] L. Piegas,et al. Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial , 1998 .
[30] D. Cook,et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.
[31] R. Diaz,et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. , 1998, Circulation.
[32] S. Yusuf,et al. Strengths and limitations of meta-analysis: larger studies may be more reliable. , 1997, Controlled clinical trials.
[33] K. Beatt,et al. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. , 1997, Circulation.
[34] J Herlitz,et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.
[35] L. Opie,et al. PROPOSED METABOLIC VICIOUS CIRCLE IN PATIENTS WITH LARGE MYOCARDIAL INFARCTS AND HIGH PLASMA-FREE-FATTY-ACID CONCENTRATIONS , 1977, The Lancet.
[36] L. Opie,et al. Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction , 1975, Nature.
[37] D. Sodi-Pallares,et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. , 1962, The American journal of cardiology.